Injection site reactions after Tdap immunization were reported in @ ( @ % -LSB- @ % CI , @ % -@ % -RSB- ) and @ ( @ % -LSB- @ % CI , @ % -@ % -RSB- ) pregnant and postpartum women , respectively ( P > @ ) .